Companies

See how salaries can vary from company to company

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its lead product candidate includes Auryxia, a ferric citrate to control the serum phosphorus levels in adult patients with chronic kidney disease (CKD), on dialysis (DD)-CKD, or the hyperphosphatemia indication (HIF); and vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to CKD in DD and non-dialysis patients. It has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the developmen... view company details

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923 candidate, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial for treating patients with interstitial lung diseases (ILDs), such as pulmonary sarcoidosis; and in Phase 1 clinical trial to treat chronic hypersensitivity pneumonitis and connective tissue disease ILD. The company has a colla... view company details

Amerityre Corporation engages in the research and development, manufacture, and sale of polyurethane tires in the United States. The company provides closed-cell polyurethane foam tires for bicycles, carts, hand trucks, lawn and garden, wheelbarrow, personnel carriers, and medical mobility products; polyurethane elastomer industrial tires for forklifts and scissor lifts; agricultural tires, including seeder tires and hay baler tires, as well as flat-free pivot tires that are used in irrigation systems; and specialty tires and tire-wheel assemblies. It serves original equipment manufacturers of... view company details

Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The company's lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of viral infections in hematopoietic or stem cell transplant recipients (HCT), as well as for the treatment of adenovirus infection and disease, smallpox, and BK virus infection in kidney and HCT transplant recipients. It is also developing CMX521, a nucleoside for the treatment of norovirus; and CMX157, a nucleoside analog for the treat... view company details

ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin, which has completed Phase II clinical trials for the treatment of staphylococcus aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible; and CF-404, a combination of monoclonal antibodies (mAbs), which is in preclinical trial stage for the treatment... view company details

Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States. The company's lead product candidate is Edasalonexent, an oral small molecule that inhibits nuclear factor kappa-light-chain-enhancer of activate B cells, which is in Phase III clinical trial for the treatment of duchenne muscular dystrophy (DMD). It is also involved in developing CAT-5571 for the treatment of cystic fibrosis. Cata... view company details

Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's product candidates include CK-101 that in the phase 1/2 clinical trial for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer; and CK-301, a programmed death ligand-1 (PD-L1), which is in phase I clinical trial in patients with selected recurrent or metastatic cancers. It also develops CK-103, a small molecule inhibitor of BET bromodomains; ... view company details

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a range of scientific, commercial, and industrial applications. It operates through two segments, OEM Laser Sources and Industrial Lasers & Systems. The company designs, manufactures, markets, and services lasers, laser tools, precision optics, and related accessories; and laser measurement and control products. Its products are used in markets, including microelectronics, materials processing, original equipment manufacturer components and instrumentation, and scientific research and government prog... view company details

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, currently being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in multiple types of solid tumors and B cell lymphomas; CDX-3379, a human monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-301, a dendritic ce... view company details

Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome in the United States. The company also develops Firdapse, which is in various clinical trials for the treatment of patients with congenital myasthenic syndrome, anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3. It has license agreemen... view company details

Centrus Energy Corp. supplies nuclear fuel and services for the commercial nuclear power industry in the United States, Japan, Belgium, and internationally. The company operates in two segments, Low-Enriched Uranium (LEU) and Contract Services. Its LEU is a component used in the production of nuclear fuel for reactors to produce electricity. The company sells separative work units (SWU) component of LEU; SWU and uranium components of LEU; and uranium for utilities that operate nuclear power plants. It also offers technical, manufacturing, and engineering services to public and private sector c... view company details

Diablo Valley Oncology provides comprehensive cancer care to patients by bringing together medical oncology, chemotherapy, radiation therapy, PET/CT and diagnostic imaging, research, and supportive care all in one convenient location. The specialized care you receive at Diablo Valley Oncology combines the best in clinical medicine with an outstanding staff and services that meet the individual needs of each patient. Diablo Valley Oncology & Hematology Medical Group (DVO) was voted one of the Top Workplaces by its employees 5 years in a row! 2001-2015 Top Workplaces is a stamp of approval from ... view company details

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs ... view company details

Ebenezer helps older adults and others make their lives more independent, healthful, meaningful and secure. With our partners at Fairview Health Services, Ebenezer provides access throughout Minnesota to a full range of senior housing options, community-based programs and medical care. Ebenezer Fairview is a not-for-profit senior health care service in Minnesota. Fairview is redefining the delivery of health care through an integrated health network, providing care from prevention and disease management to treatment of the most complex of life-threatening injuries and illnesses. Fairview's mis... view company details

Essentia Health is an integrated health system serving patients in Minnesota, Wisconsin and North Dakota. Headquartered in Duluth, Minnesota, Essentia Health combines the strengths and talents of 13,500+ employees, including more than 2,100 physicians and advanced practitioners, who serve our patients and communities through the mission of being called to make a healthy difference in people's lives. Essentia Health, which includes many Catholic facilities, is guided by the values of Quality, Hospitality, Respect, Joy, Justice, Stewardship and Teamwork. The organization lives out its mission by... view company details

Freedom Holding Corp., through its subsidiaries, provides retail securities brokerage, investment research and counseling, securities trading, market making, corporate investment banking, and underwriting services. The company offers investment brokerage services for exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange traded options and futures contracts, government bonds, and mutual funds; capital raising solutions for corporate clients through initial public offerings, follow-on offerings, and private investments in public entities; a... view company details

Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products fo... view company details

Giga-tronics Incorporated, together with its subsidiaries, designs, manufactures, and markets modular test products for electronic warfare in the Americas, Europe, Asia, and internationally. The company operates through two segments, Microsource and the Giga-tronics Division. The Microsource segment develops and manufactures a line of yttrium, iron, and garnet tuned oscillators, filters, and microwave synthesizers for use in operational applications, as well as in manufacturing a range of microwave instruments and devices. The Giga-tronics Division segment designs, manufactures, and markets a ... view company details

Gevo, Inc., a renewable chemicals and low-carbon fuel company, focuses on the development and commercialization of renewable alternatives to petroleum-based products in the United States. It operates through two segments, Gevo, Inc. and Gevo Development/Agri-Energy. The company engages in the research, development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of renewable jet and other fuels; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. In addition, the compa... view company details